Mice with liver-specific inactivation (L-SACC1) or with global null mutation of Ceacam1 (Cc1−/−) exhibit impairment in insulin clearance leading to chronic hyperinsulinemia and systemic insulin resistance (owing to downregulation of insulin receptor expression) (16–18). The gene discussed is CEACAM1; the disease is hyperinsulinism.